Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 37

1.

Endometrial Cancer in Brazil: Preparing for the Rising Incidence.

Paulino E, Nogueira-Rodrigues A, Goss PE, Faroni L, Guitmann G, Strasser-Weippl K, Bukowski A.

Rev Bras Ginecol Obstet. 2018 Oct;40(10):577-579. doi: 10.1055/s-0038-1673644. Epub 2018 Oct 23.

2.

Effects of Celecoxib and Low-dose Aspirin on Outcomes in Adjuvant Aromatase Inhibitor-Treated Patients: CCTG MA.27.

Strasser-Weippl K, Higgins MJ, Chapman JW, Ingle JN, Sledge GW, Budd GT, Ellis MJ, Pritchard KI, Clemons MJ, Badovinac-Crnjevic T, Han L, Gelmon KA, Rabaglio M, Elliott C, Shepherd LE, Goss PE.

J Natl Cancer Inst. 2018 Sep 1;110(9):1003-1008. doi: 10.1093/jnci/djy017.

3.

Quality of Life From Canadian Cancer Trials Group MA.17R: A Randomized Trial of Extending Adjuvant Letrozole to 10 Years.

Lemieux J, Brundage MD, Parulekar WR, Goss PE, Ingle JN, Pritchard KI, Celano P, Muss H, Gralow J, Strasser-Weippl K, Whelan K, Tu D, Whelan TJ.

J Clin Oncol. 2018 Feb 20;36(6):563-571. doi: 10.1200/JCO.2017.75.7500. Epub 2018 Jan 12. Erratum in: J Clin Oncol. 2018 May 20;36(15):1540.

4.

Outcomes in women with invasive ductal or invasive lobular early stage breast cancer treated with anastrozole or exemestane in CCTG (NCIC CTG) MA.27.

Strasser-Weippl K, Sudan G, Ramjeesingh R, Shepherd LE, O'Shaughnessy J, Parulekar WR, Liedke PER, Chen BE, Goss PE.

Eur J Cancer. 2018 Feb;90:19-25. doi: 10.1016/j.ejca.2017.11.014. Epub 2017 Dec 20.

PMID:
29274617
5.

Barriers to Primary Debulking Surgery for Advanced Ovarian Cancer in Latin America.

Paulino E, Nogueira Rodrigues A, Strasser-Weippl K, St Louis J, Bukowski A, Goss PE.

Int J Gynecol Cancer. 2017 Oct;27(8):1645-1649. doi: 10.1097/IGC.0000000000001098.

PMID:
28857784
6.

Epidemiology and pathophysiology of pregnancy-associated breast cancer: A review.

Ruiz R, Herrero C, Strasser-Weippl K, Touya D, St Louis J, Bukowski A, Goss PE.

Breast. 2017 Oct;35:136-141. doi: 10.1016/j.breast.2017.07.008. Epub 2017 Jul 18. Review.

PMID:
28732325
7.

Improving access to high-cost cancer drugs in Latin America: Much to be done.

Ruiz R, Strasser-Weippl K, Touya D, Herrero Vincent C, Hernandez-Blanquisett A, St Louis J, Bukowski A, Goss PE.

Cancer. 2017 Apr 15;123(8):1313-1323. doi: 10.1002/cncr.30549. Epub 2017 Feb 9. Review.

8.

Current and emerging therapies of HER2-positive metastatic breast cancer.

Hernández-Blanquisett A, Touya D, Strasser-Weippl K, Ruiz R, St Louis J, Goss P.

Breast. 2016 Oct;29:170-7. doi: 10.1016/j.breast.2016.07.026. Epub 2016 Aug 13. Review.

PMID:
27526299
9.

Extending Aromatase-Inhibitor Adjuvant Therapy to 10 Years.

Goss PE, Ingle JN, Pritchard KI, Robert NJ, Muss H, Gralow J, Gelmon K, Whelan T, Strasser-Weippl K, Rubin S, Sturtz K, Wolff AC, Winer E, Hudis C, Stopeck A, Beck JT, Kaur JS, Whelan K, Tu D, Parulekar WR.

N Engl J Med. 2016 Jul 21;375(3):209-19. doi: 10.1056/NEJMoa1604700. Epub 2016 Jun 5.

10.

Current Status and Future Projections of Breast Cancer in Asia.

Fan L, Goss PE, Strasser-Weippl K.

Breast Care (Basel). 2015 Dec;10(6):372-8. doi: 10.1159/000441818. Epub 2015 Dec 15. Review.

11.

Identification of early breast cancer patient cohorts who may benefit from lapatinib therapy.

Strasser-Weippl K, Horick N, Smith IE, O'Shaughnessy J, Ejlertsen B, Boyle F, Buzdar AU, Fumoleau P, Gradishar W, Martin M, Moy B, Piccart-Gebhart M, Pritchard KI, Lindquist D, Rappold E, Finkelstein DM, Goss PE.

Eur J Cancer. 2016 Mar;56:85-92. doi: 10.1016/j.ejca.2015.12.024. Epub 2016 Jan 30.

PMID:
26829011
12.

Cervical cancer control in Latin America: A call to action.

Bychkovsky BL, Ferreyra ME, Strasser-Weippl K, Herold CI, de Lima Lopes G Jr, Dizon DS, Schmeler KM, Del Carmen M, Randall TC, Nogueira-Rodrigues A, de Carvalho Calabrich AF, St Louis J, Vail CM, Goss PE.

Cancer. 2016 Feb 15;122(4):502-14. doi: 10.1002/cncr.29813. Epub 2015 Dec 15. Review.

13.

Progress and remaining challenges for cancer control in Latin America and the Caribbean.

Strasser-Weippl K, Chavarri-Guerra Y, Villarreal-Garza C, Bychkovsky BL, Debiasi M, Liedke PE, Soto-Perez-de-Celis E, Dizon D, Cazap E, de Lima Lopes G Jr, Touya D, Nunes JS, St Louis J, Vail C, Bukowski A, Ramos-Elias P, Unger-Saldaña K, Brandao DF, Ferreyra ME, Luciani S, Nogueira-Rodrigues A, de Carvalho Calabrich AF, Del Carmen MG, Rauh-Hain JA, Schmeler K, Sala R, Goss PE.

Lancet Oncol. 2015 Oct;16(14):1405-38. doi: 10.1016/S1470-2045(15)00218-1. Review.

PMID:
26522157
14.

Prolactin and breast cancer: The need to avoid undertreatment of serious psychiatric illnesses in breast cancer patients: A review.

Froes Brandao D, Strasser-Weippl K, Goss PE.

Cancer. 2016 Jan 15;122(2):184-8. doi: 10.1002/cncr.29714. Epub 2015 Oct 12. Review.

15.

Long-term hazard of recurrence in HER2+ breast cancer patients untreated with anti-HER2 therapy.

Strasser-Weippl K, Horick N, Smith IE, O'Shaughnessy J, Ejlertsen B, Boyle F, Buzdar AU, Fumoleau P, Gradishar W, Martin M, Moy B, Piccart-Gebhart M, Pritchard KI, Lindquist D, Rappold E, Finkelstein DM, Goss PE.

Breast Cancer Res. 2015 Apr 16;17:56. doi: 10.1186/s13058-015-0568-1.

16.

Pregnancy-associated breast cancer in women from Shanghai: risk and prognosis.

Strasser-Weippl K, Ramchandani R, Fan L, Li J, Hurlbert M, Finkelstein D, Shao ZM, Goss PE.

Breast Cancer Res Treat. 2015 Jan;149(1):255-61. doi: 10.1007/s10549-014-3219-9. Epub 2014 Dec 14.

17.

Breast cancer in China.

Fan L, Strasser-Weippl K, Li JJ, St Louis J, Finkelstein DM, Yu KD, Chen WQ, Shao ZM, Goss PE.

Lancet Oncol. 2014 Jun;15(7):e279-89. doi: 10.1016/S1470-2045(13)70567-9. Review.

PMID:
24872111
18.

Challenges to effective cancer control in China, India, and Russia.

Goss PE, Strasser-Weippl K, Lee-Bychkovsky BL, Fan L, Li J, Chavarri-Guerra Y, Liedke PE, Pramesh CS, Badovinac-Crnjevic T, Sheikine Y, Chen Z, Qiao YL, Shao Z, Wu YL, Fan D, Chow LW, Wang J, Zhang Q, Yu S, Shen G, He J, Purushotham A, Sullivan R, Badwe R, Banavali SD, Nair R, Kumar L, Parikh P, Subramanian S, Chaturvedi P, Iyer S, Shastri SS, Digumarti R, Soto-Perez-de-Celis E, Adilbay D, Semiglazov V, Orlov S, Kaidarova D, Tsimafeyeu I, Tatishchev S, Danishevskiy KD, Hurlbert M, Vail C, St Louis J, Chan A.

Lancet Oncol. 2014 Apr;15(5):489-538. doi: 10.1016/S1470-2045(14)70029-4.

PMID:
24731404
19.

Ferritin as prognostic marker in multiple myeloma patients undergoing autologous transplantation.

Strasser-Weippl K, Ludwig H.

Leuk Lymphoma. 2014 Nov;55(11):2520-4. doi: 10.3109/10428194.2014.891025. Epub 2014 Mar 18.

PMID:
24512320
20.

Suitable trial designs and cohorts for preventive breast cancer agents.

Strasser-Weippl K, Goss PE.

Nat Rev Clin Oncol. 2013 Dec;10(12):677-87. doi: 10.1038/nrclinonc.2013.174. Epub 2013 Oct 8. Review.

PMID:
24101120
21.

Extended adjuvant endocrine therapy in hormone-receptor positive breast cancer.

Strasser-Weippl K, Badovinac-Crnjevic T, Fan L, Goss PE.

Breast. 2013 Aug;22 Suppl 2:S171-5. doi: 10.1016/j.breast.2013.07.033. Review.

22.

Competing risks in low-risk breast cancer.

Strasser-Weippl K, Goss PE.

Am Soc Clin Oncol Educ Book. 2013:32-9. doi: 10.1200/EdBook_AM.2013.33.32.

23.

Planning cancer control in Latin America and the Caribbean.

Goss PE, Lee BL, Badovinac-Crnjevic T, Strasser-Weippl K, Chavarri-Guerra Y, St Louis J, Villarreal-Garza C, Unger-Saldaña K, Ferreyra M, Debiasi M, Liedke PE, Touya D, Werutsky G, Higgins M, Fan L, Vasconcelos C, Cazap E, Vallejos C, Mohar A, Knaul F, Arreola H, Batura R, Luciani S, Sullivan R, Finkelstein D, Simon S, Barrios C, Kightlinger R, Gelrud A, Bychkovsky V, Lopes G, Stefani S, Blaya M, Souza FH, Santos FS, Kaemmerer A, de Azambuja E, Zorilla AF, Murillo R, Jeronimo J, Tsu V, Carvalho A, Gil CF, Sternberg C, Dueñas-Gonzalez A, Sgroi D, Cuello M, Fresco R, Reis RM, Masera G, Gabús R, Ribeiro R, Knust R, Ismael G, Rosenblatt E, Roth B, Villa L, Solares AL, Leon MX, Torres-Vigil I, Covarrubias-Gomez A, Hernández A, Bertolino M, Schwartsmann G, Santillana S, Esteva F, Fein L, Mano M, Gomez H, Hurlbert M, Durstine A, Azenha G.

Lancet Oncol. 2013 Apr;14(5):391-436. doi: 10.1016/S1470-2045(13)70048-2.

PMID:
23628188
24.

Evaluation of diagnostic and treatment approaches towards acute dyspnea in a palliative care setting among medical students at the University of Vienna.

Pohl G, Marosi C, Dieckmann K, Goldner G, Elandt K, Hassler M, Schemper M, Strasser-Weippl K, Nauck F, Gaertner J, Watzke H.

Wien Med Wochenschr. 2012 Jan;162(1-2):18-28. doi: 10.1007/s10354-011-0046-z.

PMID:
22328050
25.

Psychosocial QOL is an independent predictor of overall survival in newly diagnosed patients with multiple myeloma.

Strasser-Weippl K, Ludwig H.

Eur J Haematol. 2008 Nov;81(5):374-9. doi: 10.1111/j.1600-0609.2008.01126.x. Epub 2008 Jul 11.

PMID:
18637124
26.

Advances in the treatment of hematological malignancies: current treatment approaches in multiple myeloma.

Ludwig H, Strasser-Weippl K, Schreder M, Zojer N.

Ann Oncol. 2007 Jul;18 Suppl 9:ix64-70. Review. No abstract available.

27.

Expression of MUM1/IRF4 mRNA as a prognostic marker in patients with multiple myeloma.

Heintel D, Zojer N, Schreder M, Strasser-Weippl K, Kainz B, Vesely M, Gisslinger H, Drach J, Gaiger A, Jäger U, Ludwig H.

Leukemia. 2008 Feb;22(2):441-5. Epub 2007 Aug 9. No abstract available.

PMID:
17690696
28.

A survey among oncologists on measures needed to improve cancer care.

Strasser-Weippl K, Ludwig H.

Onkologie. 2007 Jul;30(7):367-72. Epub 2007 Jun 27.

PMID:
17596745
29.

Increased angiogenesis in chronic idiopathic myelofibrosis: vascular endothelial growth factor as a prominent angiogenic factor.

Steurer M, Zoller H, Augustin F, Fong D, Heiss S, Strasser-Weippl K, Gastl G, Tzankov A.

Hum Pathol. 2007 Jul;38(7):1057-64. Epub 2007 Apr 18.

PMID:
17442379
31.

Prognostic relevance of cytogenetics determined by fluorescent in situ hybridization in patients having myelofibrosis with myeloid metaplasia.

Strasser-Weippl K, Steurer M, Kees M, Augustin F, Tzankov A, Dirnhofer S, Fiegl M, Simonitsch-Klupp I, Gisslinger H, Zojer N, Ludwig H.

Cancer. 2006 Dec 15;107(12):2801-6.

32.

Age and hemoglobin level emerge as most important clinical prognostic parameters in patients with osteomyelofibrosis: introduction of a simplified prognostic score.

Strasser-Weippl K, Steurer M, Kees M, Augustin F, Tzankov A, Dirnhofer S, Fiegl M, Simonitsch-Klupp I, Zojer N, Gisslinger H, Ludwig H.

Leuk Lymphoma. 2006 Mar;47(3):441-50.

PMID:
16396767
33.

Dietary flaxseed alters tumor biological markers in postmenopausal breast cancer.

Thompson LU, Chen JM, Li T, Strasser-Weippl K, Goss PE.

Clin Cancer Res. 2005 May 15;11(10):3828-35.

34.

Chromosome 7 deletions are associated with unfavorable prognosis in myelofibrosis with myeloid metaplasia.

Strasser-Weippl K, Steurer M, Kees M, Augustin F, Tzankov A, Dirnhofer S, Fiegl M, Gisslinger H, Zojer N, Ludwig H.

Blood. 2005 May 15;105(10):4146. No abstract available.

PMID:
15867421
35.

Advances in adjuvant hormonal therapy for postmenopausal women.

Strasser-Weippl K, Goss PE.

J Clin Oncol. 2005 Mar 10;23(8):1751-9. Review. No abstract available.

PMID:
15755983
36.

Prevention strategies with aromatase inhibitors.

Goss PE, Strasser-Weippl K.

Clin Cancer Res. 2004 Jan 1;10(1 Pt 2):372S-9S.

37.

Aromatase inhibitors for chemoprevention.

Goss PE, Strasser-Weippl K.

Best Pract Res Clin Endocrinol Metab. 2004 Mar;18(1):113-30. Review.

PMID:
14687601

Supplemental Content

Loading ...
Support Center